{"name":"TSH Biopharm Corporation Limited","slug":"tsh-biopharm-corporation-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"RANCAD","genericName":"RANCAD","slug":"rancad","indication":"Advanced or metastatic melanoma","status":"phase_3"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Amlodipine+Benazepril","genericName":"Amlodipine+Benazepril","slug":"amlodipine-benazepril","indication":"Hypertension","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Corever","genericName":"Corever","slug":"corever","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"RANCAD","genericName":"RANCAD","slug":"rancad","phase":"phase_3","mechanism":"RANCAD is a recombinant human anti-CTLA-4 monoclonal antibody that blocks the inhibitory checkpoint protein CTLA-4 to enhance anti-tumor immune responses.","indications":["Advanced or metastatic melanoma","Other solid tumors (under investigation in Phase 3)"],"catalyst":""},{"name":"Amlodipine+Benazepril","genericName":"Amlodipine+Benazepril","slug":"amlodipine-benazepril","phase":"marketed","mechanism":"Amlodipine relaxes blood vessels by blocking calcium channels, while benazepril lowers blood pressure by inhibiting angiotensin-converting enzyme (ACE), together reducing hypertension through complementary pathways.","indications":["Hypertension"],"catalyst":""},{"name":"Corever","genericName":"Corever","slug":"corever","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi3AJBVV95cUxNdFUtblN4eXF6Mk5KcUdZdXNIZDA1WlFRWlhlNzMtcC1ON1NCc2huOFMyZjA2SjdJNWRrdERjY1oyclNIUUhvdW5OZld5Y2E3UFJ2Y3FHaGRIWDJWUUh3QmFPVjlNOXFWZC1rZTlMdENVTlRjQ2FROExYUGRINlBCazUtbC10OThtanVqejU2bHhybDdiNFJKeEgtcGRHSG5lTG4tMkhPMWpEYVVGYmlBQjFfdDJNUXVKRkRnMnJXVTBnZWdQLWhzdlVhclZEX3hTSzF2VTJBRHJFUkdHQW5yT1hBUnVJSnpieU1xLUVmMDhxdEQ5ak5yOEhzcFdnN0h5c0ZoSmstNEVTRElOWEY3YzZGdnlLUk9IbWZxQzVFM3oxdkhaVXUxdFEzUV9GYWh4TkxHQ0N5eTk2QjhIdk1PSGtqSkdYbFhwQV9OYjN3NTN3X2NYS3hlRGItU0s?oc=5","date":"2025-12-16","type":"deal","source":"BioSpace","summary":"GenSci and RTW Investments Announce Strategic Partnership on Anti-TSHR Antibody GS-098 (YB-101) for Graves’ Disease and Thyroid Eye Disease, With Global Ex-China Development Being Led by Yarrow Biosci","headline":"GenSci and RTW Investments Announce Strategic Partnership on Anti-TSHR Antibody GS-098 (YB-101) for Graves’ Disease and ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiQkFVX3lxTE4zbDh0eVlGWkNxdS1iUlRIbFF2Zi1mN3U1Z1hGWTVZTWstYV9yNGlDZU5aTHI3RnhhU2x0R0VqZ1VJZw?oc=5","date":"2025-07-02","type":"pipeline","source":"CSRone 永續智庫","summary":"Asia Responsible Enterprise Awards 2025 Honors 81 ESG Champions of Asia - CSRone 永續智庫","headline":"Asia Responsible Enterprise Awards 2025 Honors 81 ESG Champions of Asia - CSRone 永續智庫","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOeWlNbklyRjJ0V2ZBV244QXp0bkFTQ19KYTV3X0o0V1V6M2lxS2lFMk1XbFpXUzJRMjRyQ01TYlVZV3dIRW44cE0teExSTUN3bnNXX2RJcGpnSklUTFJZRVJ2WTlycWdpOGh2X2hMOUw2aklUWm5wcjdXeThESVJOTUhWY3dGb0dLTFVR?oc=5","date":"2021-02-05","type":"patent","source":"Lexology","summary":"The Doctrine of Estoppel in Patent Infringement Litigation - TSH Biopharm Co., Ltd. v. China Chemical & Pharmaceutical Co., Ltd. - Lexology","headline":"The Doctrine of Estoppel in Patent Infringement Litigation - TSH Biopharm Co., Ltd. v. China Chemical & Pharmaceutical C","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE4wNTMyVDBCa1NXR1c3VWZGN05QQmpSTE5XeXV1b0R0dG9YWlpxNm1iRHRWSERHOVYyVEg4TllkNndiRDRNMFpXR3VaaFNaYU00NnFHcUhNQ2NKenZFMFQ0ejQwaUdHdw?oc=5","date":"2017-12-06","type":"pipeline","source":"sg.finance.yahoo.com","summary":"Golden Biotechnology Corporation (4132.TWO) income statement - sg.finance.yahoo.com","headline":"Golden Biotechnology Corporation (4132.TWO) income statement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTFBvYkRJYzhwT25fQW9GU1FzUU1fSHFfTFZuWm9sSXVCSjZRd0RSRk51VWMzMU5BRUhRdjVKamlwdldnM3ZaSzJxcFg4UzR1VldvR3JkV1ZHSQ?oc=5","date":"2017-09-08","type":"pipeline","source":"sg.finance.yahoo.com","summary":"Orient EuroPharma Co., Ltd. (4120.TWO) stock price, news, quote and history - sg.finance.yahoo.com","headline":"Orient EuroPharma Co., Ltd. (4120.TWO) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTE1FYVFwakVCQXBlZURwVDBWTlBUQjNDYVozZHA3MmNGSWxfTXdkRnRWNXhFZFZOb3BzSGpScXE2Qk5qb0Y2X3EtWmZ6a3BsWUxwYjRrVzM5cw?oc=5","date":"2017-05-19","type":"pipeline","source":"sg.finance.yahoo.com","summary":"Synmosa Biopharma Corporation (4114.TWO) stock price, news, quote and history - sg.finance.yahoo.com","headline":"Synmosa Biopharma Corporation (4114.TWO) stock price, news, quote and history","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_3":2,"marketed":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}